The balance of cash and cash equivalents in the company's asset statement has been showing a rapid downward trend in recent years. High R&D expenditures and performance losses are the main reasons. If it continues to decrease, the company is expected to face a liquidity problem in two years. Later, it will have to increase debt financing such as bank loans to support continued high R&D expenditures, which will further affect profits. The darkest moment will become the norm. Will the company's capital chain face the above-mentioned tension in the future and what measures will be taken to deal w

NavInfo: Hello, the company will continue to work hard to improve cash flow, and the situation you mentioned will not occur. Thank you.